Afrezza will either be approved or not. If not, MNKD is done. But if it is approved, it may represent a good investment opportunity at this time. I am trying to develop a sense as to how good. In that regard I have some questions, and would appreciate best possible responses to the following questions.

What is the true market cap of MNKD taking into consideration present fully diluted number of shares? I am looking for best approximation at today’s pps.

What is the likely time frame for Afrezza’s approval, assuming that it will be approved?

How much more funds would MNKD need until the launch of Afrezza.

What is the outstanding debt of MNKD?

When did MNKD started the development of inhalable insulin?

How much money MNKD has spent to-date on the development of inhalable insulin?

What is the expected sales ramp up profile in the US for the first few years for Afrezza based on the present manufacturing capacity as well as the possible expansion within the existing facility.

Thanks.